PLIVA HRVATSKA DOO
GenericsPLIVA HRVATSKA DOO is a generic drug manufacturer focused on Cardiovascular, Neurology.
PLIVA HRVATSKA DOO's Key Drugs
PLIVA HRVATSKA DOO's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
PLIVA HRVATSKA DOO's Recent FDA Approvals
New NDA/BLA approvals for PLIVA HRVATSKA DOO over the last two years — novel drugs only, excluding generics and label supplements.
PLIVA HRVATSKA DOO's Therapeutic Areas
PLIVA HRVATSKA DOO's approved drugs and pipeline span 2 therapeutic areas, led by Cardiovascular and Neurology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
PLIVA HRVATSKA DOO's Top Competitors
PLIVA HRVATSKA DOO's closest competitors by therapeutic-area and drug-target overlap include GE HEALTHCARE, Novo Nordisk, and LEDERLE. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
PLIVA HRVATSKA DOO Pipeline Snapshot
Active clinical trials for PLIVA HRVATSKA DOO across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2006-12-26
- Latest
- 2021-06-07
- Applications
- 10